News Releases :: Skye Bioscience, Inc. (SKYE)

Year

Category

Apr 15, 2025 7:00 am EDT

Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model

Apr 14, 2025 7:00 am EDT

Skye Bioscience to Conduct Meetings at Piper Sandler Conference

Mar 20, 2025 4:01 pm EDT

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 14, 2025 7:00 am EDT

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

Feb 27, 2025 6:00 pm EST

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Feb 24, 2025 7:00 am EST

Skye Bioscience to Participate in SXSW Session on Obesity

Feb 20, 2025 7:00 am EST

Skye Bioscience to Present at TD Cowen Health Care Conference

Feb 4, 2025 7:00 am EST

Skye Bioscience Announces Participation in February Conferences

Jan 13, 2025 7:00 am EST

Skye Bioscience Provides 2025 Look Ahead and Year in Review

Dec 19, 2024 7:00 am EST

Skye Bioscience to Present at J.P. Morgan Healthcare Conference